Depomed Inc (NASDAQ:DEPO), had its price target upped by Roth Capital from $12.50 to $14.00 in a research note issued to investors on Friday, American Banking News.com reports. Depomed Inc (NASDAQ:DEPO), shares after opening at $13.28 moved to $14.34 on last trade day and at the end of the day closed at $14.28. Company price to sales ratio in past twelve months was calculated as 6.15 and price to cash ratio as 3.03. Depomed Inc (NASDAQ:DEPO), showed a positive weekly performance of 11.30%.
Synthetic Biologics Inc (NYSEMKT:SYN)’s stock is trading at $2.63. The company on Mar. 31 reported financial results for the year ended December 31, 2013 and provided operational highlights. General and administrative expenses increased to $5.8 million for the year ended December 31, 2013, compared to $5.0 million for the same period in 2012. Other income was $21,000 for the year ended December 31, 2013, compared to $15,000 for the same period in 2012. Cash as of December 31, 2013 was $14.6 million, compared to $10.0 million as of December 31, 2012. As of March 27, 2014, the Company’s cash balance was approximately $11.3 million. Synthetic Biologics Inc (NYSEMKT:SYN), shares advanced 6.19% in last trading session and ended the day on $3.09. Synthetic Biologics Inc (NYSEMKT:SYN), return on equity ratio is recorded as -115.80% and its return on assets is -110.30%. Synthetic Biologics Inc (NYSEMKT:SYN), yearly performance is 103.29%.
Array Biopharma Inc (NASDAQ:ARRY), will report financial results for the third quarter of fiscal 2014 and hold a conference call to discuss those results on Tuesday, April 29, 2014. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call. Array Biopharma Inc (NASDAQ:ARRY), shares moved up 7.63% in last trading session and was closed at $4.09, while trading in range of $ 3.80 – 4.22. Array Biopharma Inc (NASDAQ:ARRY), year to date (YTD) performance is -18.36%.
Prothena Corporation PLC (NASDAQ:PRTA), was a big mover last session, as the company saw its shares rally nearly 10.00% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $26.26 to $40.07 in the past one-month time frame, showed a pick-up yesterday at $36.95. Prothena Corporation PLC (NASDAQ:PRTA), weekly performance is 41.15%. On last trading day company shares ended up $39.62. Prothena Corporation PLC (NASDAQ:PRTA), distance from 50-day simple moving average (SMA50) is 14.57%.